The self-constructed CELLO2 is open to the public, and could accurately predict whether the recurrent tumor will progress into more aggressive forms under the TMZ treatment, and to identify patients of higher risk. (IMAGE)

Hong Kong University of Science and Technology

The self-constructed CELLO2 is open to the public, and could accurately predict whether the recurrent tumor will progress into more aggressive forms under the TMZ treatment, and to identify patients of higher risk.

Caption

The self-constructed CELLO2 is open to the public, and could accurately predict whether the recurrent tumor will progress into more aggressive forms under the TMZ treatment, and to identify patients of higher risk.

Credit

HKUST

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.